[Macroprogestative contraception: advantages].
Jamin
C
C
D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D004703:Endocrine System; D004958:Estradiol; D004967:Estrogens; D005060:Europe; D005193:Family Planning Services; D005602:France; D006728:Hormones; D006805:Human Experimentation; D008660:Metabolism; D010827:Physiology; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004967:Estrogens; D006728:Hormones; D004958:Estradiol
Biology; Clinical Research; Contraception; Contraception Research; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Developed Countries; Endocrine System; Estradiol; Estrogens; Europe; Family Planning; France; Hormones; Human Volunteers--women; Mediterranean Countries; Metabolic Effects; Physiology; Research Methodology; Western Europe